Compositions and methods for cancer diagnosis
NZ837720APending Publication Date: 2026-10-30AOA DX
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ837720
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-10-05
- Filing Date
- 2021-10-05
- Publication Date
- 2026-10-30
Smart Images

Figure 00000156_0000 
Figure 00000156_0001 
Figure 00000156_0002
Abstract
The present disclosure provides monoclonal antibodies and antigen-binding fragments thereof that specifically bind to gangliosides (e.g., GD2 or GD3), as well as compositions comprising same and methods of using same for diagnostic and prognostic purposes. In addition, the present disclosure provides mass spectrometry-based methods for detecting various gangliosides and their lipid length, the changes of which are useful for the cancer diagnostic and prognostic methods described herein. The present disclosure further provides compounds comprising modified versions of gangliosides.
Need to check novelty before this filing date? Find Prior Art
